...
首页> 外文期刊>International immunopharmacology >Sesquiterpene lactone potentiates the immunomodulatory, antiparasitic and cardioprotective effects on anti-Trypanosoma cruzi specific chemotherapy
【24h】

Sesquiterpene lactone potentiates the immunomodulatory, antiparasitic and cardioprotective effects on anti-Trypanosoma cruzi specific chemotherapy

机译:SesquiterPene内酯强调免疫调节,抗孕腺和心脏保护作用对抗蛋白酶瘤Cruzi特异性化疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We investigated the immunomodulatory, antiparasitic and cardioprotective effects of a sesquiterpene lactone (SL) administered alone or combined with benznidazole (Bz), in a murine model of Chagas' disease by in vitro and in vivo assays. Antiparasitic and cytotoxic potential of tagitinin C (SL) and Bz were tested in vitro against T. cruzi epimastigotes and cardiomyocytes. Swiss mice challenged with T. cruzi were also treated for 20 days with tagitinin C (10 mg/kg) alone and combined with Bz (100 mg/kg). Tagitinin C exhibited a higher antiparasitic (IC50: 1.15 mu M) and cytotoxic (CC50 at 6.54 mu M) potential than Bz (IC50: 35.81 mu M and CC50, 713.5 mu M, respectively). When combined, these drugs presented an addictive interaction, determining complete suppression of parasitemia and parasitological cure in all infected mice (100%) compared to those receiving Bz alone (70%). Anti-T. cruzi immunoglobulin G, and pro-inflammatory cytokines IFN-gamma and TNF-alpha levels were reduced in animals treated with tagitinin C combined with Bz, while IL-10 production was unaffected. Heart inflammation was undetectable in 90% of the animals receiving this combination, while only 50% of the animals receiving Bz alone showed no evidence of myocarditis. Together, our findings indicated that the combination of tagitinin C and Bz exerts potent antiparasitic, immunomodulatory and cardioprotective effects. Due to the remarkable suppression of parasitemia and high parasitological cure, this combination was superior to Bz monotherapy, indicating a high potential for the treatment of Chagas's disease.
机译:通过体外和体内测定,通过体外和体内测定,研究单独给药或与苯并咪唑(BZ)联合苯并咪唑(BZ)的免疫调节,抗寄生虫和心脏保护作用。在体外测试标记蛋白蛋白C(SL)和BZ的抗遗传性和细胞毒性潜力对抗T.Cruzi ePimastigotes和心肌细胞。用T.Cruzi挑战的瑞士小鼠也用标记蛋白C(10mg / kg)处理20天并与BZ(100mg / kg)合并。 Tagitinin C表现出比BZ的更高的抗抗原性(IC50:1.15μm)和细胞毒性(CC50,CC50,分别为35.81μm和CC50,713.5μm。结合时,这些药物呈现成瘾的相互作用,与单独接受BZ(70%)相比,确定所有感染的小鼠(100%)中的寄生虫和寄生虫治疗的完全抑制。抗T。在用标记蛋白C合并与BZ处理的动物处理的动物中减少了Cruzi免疫球蛋白G和促炎细胞因子IFN-Gamma和TNF-α水平,而IL-10产生不受影响。在接受这种组合的90%的动物中,心脏炎症不可检测到,而仅接受BZ的动物只有50%的动物没有表现出心肌炎的证据。我们的研究结果在一起表明Tagitinin C和BZ的组合施加有效的抗遗传性,免疫调节和心脏保护作用。由于血糖血症和高寄生虫治疗的显着抑制,这种组合优于BZ单疗法,表明抑制棘伽士疾病的潜力很高。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号